When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 11 Hits
  • Search Condition : Filter (MeSH = Ovarian Neoplasms / drug therapy*)
Species Resource
Human and Animal Cells JHOC-5(RCB1520) Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Human and Animal Cells JHOS-2(RCB1521) A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Human and Animal Cells JHOC-5(RCB1520) ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Human and Animal Cells Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.
Human and Animal Cells OV2944-HM-1(RCB1483) AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer.
Human and Animal Cells IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Human and Animal Cells Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Human and Animal Cells Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Human and Animal Cells NIH:OVCAR-3 (RCB2135) Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
Human and Animal Cells NIH:OVCAR-3 (RCB2135) Sawano (RCB1152) Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer.
Human and Animal Cells OV2944- HM-1(RCB1483) Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.